Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants.

PKD PKLR enzyme haemolytic anaemia pyruvate kinase

Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
29 May 2024
Historique:
received: 09 12 2022
accepted: 18 05 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 29 5 2024
Statut: aheadofprint

Résumé

Pyruvate kinase (PK) is a key enzyme of anaerobic glycolysis. The genetic heterogeneity of PK deficiency (PKD) is high, and over 400 unique variants have been identified. Twenty-nine patients who had been diagnosed as PKD genetically in seven distinct paediatric haematology departments were evaluated. Fifteen of 23 patients (65.2%) had low PK levels. The PK:hexokinase ratio had 100% sensitivity for PKD diagnosis, superior to PK enzyme assay. Two novel intronic variants (c.695-1G>A and c.694+43C>T) have been described. PKD should be suspected in patients with chronic non-spherocytic haemolytic anaemia, even if enzyme levels are falsely normal. Total PKLR gene sequencing is necessary for the characterization of patients with PKD and for genetic counselling.

Identifiants

pubmed: 38811201
doi: 10.1111/bjh.19575
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Erciyes Üniversitesi
ID : 2021-10863

Informations de copyright

© 2024 British Society for Haematology and John Wiley & Sons Ltd.

Références

Aksu T. Hereditary red blood cell enzymopathies. J Pediatr Acad. 2021;2(1):9–13.
Bianchi P, Fermo E, Glader B, Kanno H, Agarwal A, Barcellini W, et al. Addressing the diagnostic gaps in pyruvate kinase deficiency: consensus recommendations on the diagnosis of pyruvate kinase deficiency. Am J Hematol. 2019;94(1):149–161.
Karaca M, Gök V, Alakuş Sarı Ü, Dündar MA, Aydin F, Özcan A, et al. Triosephosphate isomerase deficiency in an infant. J Transl Pract Med. 2022;1(2):65–67.
Valentine WN, Tanaka KR, Miwa S. A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non‐spherocytic hemolytic anemia. Trans Assoc Am Phys. 1961;74:100–110.
Aydin Köker S, Oymak Y, Bianchi P, Gözmen S, Karapinar TH, Fermo E, et al. A new variant of PKLR gene associated with mild hemolysis may be responsible for the misdiagnosis in pyruvate kinase deficiency. J Pediatr Hematol Oncol. 2019;41(1):e1–e2.
Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, et al. Erythrocyte pyruvate kinase deficiency: 2015 status report. Am J Hematol. 2015;90(9):825–830.
Grace RF, Barcellini W. Management of pyruvate kinase deficiency in children and adults. Blood. 2020;136(11):1241–1249.
Svidnicki MCCM, Santos A, Fernandez JAA, Yokoyama APH, Magalhães IQ, Pinheiro VRP, et al. Novel mutations associated with pyruvate kinase deficiency in Brazil. Rev Bras Hematol Hemoter. 2018;40(1):5–11.
Bianchi P, Fermo E, Lezon‐Geyda K, van Beers EJ, Morton HD, Barcellini W, et al. Genotype‐phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency. Am J Hematol. 2020;95(5):472–482.
Ozdemir MA, Yilmaz K, Abdulrezzak U, Muhtaroglu S, Patiroglu T, Karakukcu M, et al. The efficacy of vitamin K2 and calcitriol combination on thalassemic osteopathy. J Pediatr Hematol Oncol. 2013;35(8):623–627.
Akyol Ş, Tahiroğlu A, Ünal E. Inherited hemolytic anemias in children. Kastamonu Med J. 2022;2(4):90–94.
Camaschella C, Nai A. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias. Br J Haematol. 2016;172(4):512–523.
Mojzikova R, Koralkova P, Holub D, Zidova Z, Pospisilova D, Cermak J, et al. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios. Br J Haematol. 2014;165(4):556–563.
Van Beers EJ, van Straaten S, Morton DH, Barcellini W, Eber SW, Glader B, et al. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the pyruvate kinase deficiency natural history study. Haematologica. 2019;104(2):e51–e53.
Al‐Samkari H, Addonizio K, Glader B, Morton DH, Chonat S, Thompson AA, et al. The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency. Br J Haematol. 2021;192(6):1092–1096.

Auteurs

Veysel Gök (V)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.

Göksel Leblebisatan (G)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Çukurova University, Adana, Türkiye.

Dilek Gürlek Gökçebay (D)

Department of Paediatric Haematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Türkiye.

Salih Güler (S)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Uludağ University, Bursa, Türkiye.

Muhammet Ensar Doğan (ME)

Department of Medical Genetics, Faculty of Health Sciences, Kayseri City Hospital, Kayseri, Türkiye.

Sevcan Tuğ Bozdoğan (S)

Department of Medical Genetics, Faculty of Medicine, Cukurova University, Adana, Türkiye.
Adana Genetic Diseases Diagnosis and Treatment Center (AGENTEM), Cukurova University, Adana, Türkiye.

Ayça Koca Yozgat (A)

Department of Paediatric Haematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Türkiye.

Alper Özcan (A)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.

Esra Pekpak Şahinoğlu (E)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.

Hüseyin Tokgöz (H)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.

Metin Çil (M)

Department of Paediatric Haematology and Oncology, Faculty of Health Sciences, Adana City Hospital, Adana, Türkiye.

Şebnem Özemri Sağ (Ş)

Department of Medical Genetics, Faculty of Medicine, Uludag University, Bursa, Türkiye.

Ebru Yilmaz (E)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.

Hatice İlgen Şaşmaz (Hİ)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Çukurova University, Adana, Türkiye.
Department of Paediatric Bone Marrow Transplantation, Adana Acıbadem Hospital, Adana, Türkiye.

Melike Sezgin Evim (MS)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Uludağ University, Bursa, Türkiye.

Sinan Akbayram (S)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.

Meriban Karadoğan (M)

Department of Paediatric Haematology and Oncology, Faculty of Health Sciences, Kayseri City Hospital, Kayseri, Türkiye.

Fatma Türkan Mutlu (FT)

Department of Paediatric Haematology and Oncology, Faculty of Health Sciences, Kayseri City Hospital, Kayseri, Türkiye.

İbrahim Boğa (İ)

Department of Medical Genetics, Faculty of Medicine, Cukurova University, Adana, Türkiye.
Adana Genetic Diseases Diagnosis and Treatment Center (AGENTEM), Cukurova University, Adana, Türkiye.

Burcu Yeter Doğan (B)

Department of Paediatric Genetic, Faculty of Health Sciences, Kayseri City Hospital, Kayseri, Türkiye.

Neşe Yarali (N)

Department of Paediatric Haematology and Oncology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Türkiye.

Ümran Çalişkan (Ü)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Department of Paediatric Haematology and Oncology, Faculty of Medicine, KTO Karatay University, Konya, Türkiye.

Atil Bişgin (A)

Department of Medical Genetics, Faculty of Medicine, Cukurova University, Adana, Türkiye.
Adana Genetic Diseases Diagnosis and Treatment Center (AGENTEM), Cukurova University, Adana, Türkiye.

Şehime Gülsün Temel (ŞG)

Department of Medical Genetics, Faculty of Medicine, Uludag University, Bursa, Türkiye.
Department of Histology, Faculty of Medicine, Uludağ University, Bursa, Türkiye.

Melanie Proven (M)

Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Kate Gibson (K)

Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Büşra Şeniz Demir (BŞ)

Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.

Hatice Saraçoğlu (H)

Department of Medical Biochemistry, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Drug Application and Research Center, Erciyes University, Kayseri, Türkiye.

Ahmet Eken (A)

Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Molecular Biology and Genetics Department, Genome and Stem Cell Centre (GENKOK), Gevher Nesibe Genom and Stem Cell Institution, Erciyes University, Kayseri, Türkiye.

Çiğdem Karakükçü (Ç)

Department of Medical Biochemistry, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Drug Application and Research Center, Erciyes University, Kayseri, Türkiye.

Musa Karakükçü (M)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.

Adalet Meral Güneş (AM)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Uludağ University, Bursa, Türkiye.

Namık Yaşar Özbek (NY)

Department of Paediatric Haematology and Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Türkiye.

Yurdanur Kilinç (Y)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Çukurova University, Adana, Türkiye.

Türkan Patiroğlu (T)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.

Mehmet Akif Özdemir (MA)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.

Noemi B A Roy (NBA)

Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Molecular Haematology Laboratory, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Ekrem Ünal (E)

Division of Paediatric Haematology and Oncology, Department of Paediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Medical Point Hospital, Paediatric Haematology and Oncology Clinic, Gaziantep, Türkiye.
School of Health Sciences, Hasan Kalyoncu University, Gaziantep, Türkiye.

Classifications MeSH